道琼斯指数
48,147.33
涨跌
-949.73-1.92%
在 MEXC 探索美国生物科技板块股票,涵盖专注于药物研发、基因治疗及生物学研究的公司。比较股价、当日涨跌、市值和成交量,全面了解生物科技行业动态。

今日股票市场整体下跌,道琼斯指数下跌 1.92%,标普 500 指数下跌 3.70%,纳斯达克综合指数下跌 5.28%。市场广度偏弱,4,363 只股票下跌、757 只上涨,整体呈现偏空格局。
| # | 股票 | 52 周价格区间 | |||||
|---|---|---|---|---|---|---|---|
| 51 | Iambic Therapeutics, Inc.IAM | $13.18 | -9.19% | 275.03K | $675.94M | $9.60 - $25.00 | 0.00% |
| 52 | Prime MedicinePRME | $3.56 | -7.03% | 5.40M | $646.25M | $2.67 - $5.91 | 0.00% |
| 53 | Cullinan Oncology LLCCGEM | $8.91 | -1.71% | 825.31K | $578.58M | $8.47 - $23.19 | 0.00% |
| 54 | 4D MolecularFDMT | $10.22 | -4.76% | 519.66K | $575.97M | $6.96 - $16.93 | 0.00% |
| 55 | Entera BioENTX | $3.30 | +0.91% | 456.26K | $574.48M | $0.91 - $4.20 | 0.00% |
| 56 | DBV Technologies S.A.DBVT | $9.03 | -4.35% | 148.36K | $567.79M | $8.63 - $26.18 | 0.00% |
| 57 | Electra Therapeutics, Inc.ETRA | $8.13 | -8.95% | 348.46K | $562.03M | $6.87 - $15.50 | 0.00% |
| 58 | SurrozenSRZN | $28.45 | -7.86% | 127.71K | $542.27M | $12.79 - $37.83 | 0.00% |
| 59 | NRC HealthNRC | $25.17 | +0.76% | 62.70K | $534.15M | $11.73 - $27.60 | 0.03% |
| 60 | RegenxbioRGNX | $7.17 | -0.14% | 829.91K | $474.03M | $5.46 - $16.19 | 0.00% |
| 61 | Sana BiotechnologySANA | $1.58 | -9.20% | 3.83M | $473.12M | $1.56 - $5.49 | 0.00% |
| 62 | Fennec Pharmaceuticals Inc.FENC | $13.09 | -2.60% | 338.96K | $460.96M | $5.65 - $13.85 | 0.00% |
| 63 | IRulya Therapeutics Inc.IRLA | $39.87 | +0.95% | 195.94K | $432.20M | $25.13 - $45.00 | 0.00% |
| 64 | Tectonic TherapeuticTECX | $20.72 | -1.62% | 235.20K | $413.38M | $16.77 - $39.53 | 0.00% |
| 65 | Ginkgo BioworksDNA | $7.46 | -7.93% | 2.28M | $402.31M | $5.37 - $18.22 | 0.00% |
| 66 | Candel TherapeuticsCADL | $5.03 | -1.75% | 1.49M | $385.19M | $4.35 - $14.00 | 0.00% |
| 67 | AlectorALEC | $2.33 | +1.74% | 1.86M | $347.63M | $1.09 - $2.84 | 0.00% |
| 68 | C4CCCC | $2.48 | +1.64% | 3.32M | $326.32M | $1.69 - $5.17 | 0.00% |
| 69 | X4 PharmaceuticalsXFOR | $3.00 | +1.69% | 1.75M | $297.94M | $2.43 - $4.83 | 0.00% |
| 70 | TRex Bio, Inc.TRXB | $10.09 | +3.91% | 88.32K | $279.83M | $9.06 - $16.56 | 0.00% |
| 71 | 艾吉纳斯AGEN | $5.97 | -2.85% | 618.89K | $270.17M | $2.71 - $10.31 | 0.00% |
| 72 | Kyverna TherapeuticsKYTX | $4.25 | -2.75% | 1.18M | $268.63M | $4.17 - $13.67 | 0.00% |
| 73 | OcugenOCGN | $0.77 | +4.46% | 5.82M | $260.25M | $0.69 - $2.73 | 0.00% |
| 74 | Eikon TherapeuticsEIKN | $4.75 | +0.11% | 619.80K | $257.93M | $4.54 - $17.40 | 0.00% |
| 75 | SAB BiotherapeuticsSABS | $2.82 | -3.09% | 797.72K | $253.96M | $2.44 - $5.15 | 0.00% |
| 76 | Editas MedicineEDIT | $1.64 | -4.68% | 2.08M | $252.35M | $1.63 - $3.94 | 0.00% |
| 77 | Scribe TherapeuticsSCTX | $12.03 | -8.55% | 281.76K | $250.35M | $12.00 - $39.60 | 0.00% |
| 78 | Lexeo TherapeuticsLXEO | $2.97 | +0.51% | 1.66M | $243.35M | $2.55 - $10.99 | 0.00% |
| 79 | ProKidneyPROK | $1.04 | -1.89% | 1.76M | $218.38M | $0.87 - $2.65 | 0.00% |
| 80 | Allogene TherapeuticsALLO | $0.62 | -6.39% | 6.87M | $216.20M | $0.62 - $4.46 | 0.00% |
| 81 | Century TherapeuticsIPSC | $1.17 | -11.74% | 807.68K | $211.56M | $0.48 - $3.04 | 0.00% |
| 82 | Precision BioSciencesDTIL | $7.38 | +7.02% | 374.42K | $206.31M | $3.53 - $11.29 | 0.00% |
| 83 | Cabaletta BioCABA | $0.94 | -7.09% | 3.42M | $202.56M | $0.93 - $4.23 | 0.00% |
| 84 | Alpha CognitionACOG | $8.98 | +1.47% | 261.94K | $195.57M | $4.50 - $10.14 | 0.00% |
| 85 | Artiva BiotherapeuticsARTV | $3.79 | -1.04% | 1.69M | $187.45M | $2.96 - $14.53 | 0.00% |
| 86 | InhibikaseIKT | $1.31 | +0.38% | 991.84K | $184.45M | $1.22 - $2.61 | 0.00% |
| 87 | Palisade BioPALI | $0.85 | -8.23% | 3.00M | $152.57M | $0.84 - $2.85 | 0.00% |
| 88 | Sutro BiopharmaSTRO | $8.61 | -1.26% | 241.87K | $142.86M | $7.15 - $43.85 | 0.00% |
| 89 | MaxCyteMXCT | $1.38 | +7.42% | 1.08M | $141.97M | $0.64 - $1.80 | 0.00% |
| 90 | Protara TherapeuticsTARA | $2.27 | -5.00% | 993.30K | $140.07M | $2.09 - $7.82 | 0.00% |
| 91 | HumacyteHUMA | $0.45 | -17.88% | 5.73M | $123.62M | $0.34 - $1.52 | 0.00% |
| 92 | Compass Therapeutics,CMPX | $0.69 | +1.12% | 1.50M | $123.36M | $0.57 - $6.88 | 0.00% |
| 93 | InvivydIVVD | $0.42 | -6.23% | 4.76M | $122.91M | $0.41 - $3.01 | 0.00% |
| 94 | enGene TherapeuticsENGN | $1.73 | -1.14% | 538.09K | $116.21M | $1.40 - $12.25 | 0.00% |
| 95 | Fate TherapeuticsFATE | $0.93 | -8.37% | 3.63M | $112.45M | $0.90 - $3.23 | 0.00% |
| 96 | Tevogen Bio HoldingsTVGN | $6.05 | -5.32% | 6.90K | $95.28M | $3.64 - $24.91 | 0.00% |
| 97 | Voyager TherapeuticsVYGR | $1.52 | -5.59% | 561.59K | $94.90M | $1.48 - $5.48 | 0.00% |
| 98 | OUTLOOK THERAPEUTICSOTLK | $0.39 | -3.82% | 4.90M | $94.21M | $0.16 - $2.54 | 0.00% |
| 99 | LENZ TherapeuticsLENZ | $2.97 | -11.08% | 854.80K | $93.26M | $2.80 - $32.13 | 0.00% |
| 100 | Zura Bio LimitedZURA | $0.92 | -2.95% | 4.46M | $88.91M | $0.92 - $7.44 | 0.00% |
| 现货股票 | 代币化股票(Tokenized Stocks) | 股票合约(Stock Futures) | |
|---|---|---|---|
| 是什么 | 股票上市公司对应股票所有权(现货股票) | 与股票/ETF 挂钩的区块链代币 | 以 USDT 保证金进行的股价合约交易 |
| 所有权 | 是 —— 真实持股 | 否 —— 仅为合成敞口 | 否 —— 仅为衍生品敞口 |
| 股东权益 | 有(如分红) | 无 | 无 |
| 交易时间 | 股票交易时段(盘前、正常、盘后、隔夜) | 24/7 全天候 | 支持交易对最高可达 24/7 全天候 |
| 持仓方式 | 买入并持有 | 买入并持有 | 支持多空双向、杠杆交易 |
| 适合人群 | 追求长期持有和分红收益的投资者 | 希望全天候获得股票敞口、无需持有股票的交易者 | 希望通过杠杆进行投机或对冲的短线/活跃交易者 |
通过 MEXC 合作的持牌券商购买股票,并可按适用条件享有股息等股东权益。
覆盖 7,000+ 只美国上市股票及 ETF,涵盖科技、金融、医疗、消费等多个行业。
支持 USDT 转入及 USDT/USD 转换,更便捷地为股票账户提供资金。
以具有竞争力的交易成本参与股票交易,让更多资金用于投资策略。
本页面展示的股票价格、指数、排行榜、图表及其他市场数据可能来自第三方数据提供商,并可能存在延迟或误差。MEXC 提供的相关信息仅供参考和教育用途,不对其准确性或完整性作出保证。页面内容不构成任何金融或投资建议,也不构成买卖任何证券的推荐。股票交易存在风险,历史表现不代表未来结果,用户应在作出投资决定前进行独立研究。